NASDAQ / LIVE COMPANY INTELLIGENCE

Cibus, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERCBUS
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / CBUS COVERAGE

What’s moving Cibus, Inc. now

Current reporting with the operating signal separated from the noise.

01
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants

Investors are testing whether Cibus, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Cibus, Inc. (NASDAQ:CBUS) surges 15%; individual investors who own 43% shares profited along with insiders

Cibus, Inc. (NASDAQ:CBUS) surges 15%; individual investors who own 43% shares profited along with insiders

Investors are testing whether Cibus, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering

Cibus, Inc. Announces Pricing of $27.5 Million Public Offering

The story matters when it changes Cibus, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Cibus, Inc. to Present Advances in Gene-Editing Technology at AGP Annual Virtual Healthcare Company Showcase

Cibus, Inc. to Present Advances in Gene-Editing Technology at AGP Annual Virtual Healthcare Company Showcase

The story matters when it changes Cibus, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Cibus, Inc. Reports Promising Initial Bioassay Results for Third Sclerotinia Resistance Trait in Canola

Cibus, Inc. Reports Promising Initial Bioassay Results for Third Sclerotinia Resistance Trait in Canola

The development tests whether Cibus, Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest CBUS filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-17 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-09 · Period 2026-06-08SEC ↗8-KMaterial company eventFiled 2026-06-05 · Period 2026-06-02SEC ↗8-KMaterial company eventFiled 2026-05-14 · Period 2026-05-14SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-20 · Period 2026-06-02SEC ↗S-8Official SEC filingFiled 2026-06-23SEC ↗
EARNINGS / QUARTERLY TRACKER

Cibus, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.